Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience

S K Sarin1

  • 1Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India.

Insights

Gastric variceal sclerotherapy effectively stops bleeding and obliterates varices, especially gastroesophageal varices type 1. Alternative treatments are needed for isolated gastric varices type 1 due to higher rebleeding rates.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Endoscopic interventions

Background:

  • Gastric variceal bleeding is a critical medical emergency.
  • Endoscopic management strategies for gastric varices remain debated.
  • Classification and targeted treatments for different gastric varice types are needed.

Purpose of the Study:

  • To evaluate the efficacy of gastric variceal sclerotherapy in managing bleeding and achieving obliteration.
  • To compare treatment outcomes across different classifications of gastric varices.
  • To identify patient groups that may benefit from alternative therapeutic approaches.

Main Methods:

  • Gastric varices were classified into gastroesophageal varices type 1 (GOV1), type 2 (GOV2), and isolated gastric varices type 1 (IGV1).
  • Sclerotherapy involved weekly paravariceal and intravariceal injections of absolute alcohol.
  • Outcomes assessed included acute bleeding control, variceal obliteration, rebleeding rates, and mortality.

Main Results:

  • Sclerotherapy arrested acute bleeding in 66.7% of emergency cases.
  • Overall variceal obliteration was achieved in 71.6% of patients undergoing elective sclerotherapy.
  • Obliteration rates were highest for GOV1 (94.4%), followed by GOV2 (70.4%), and lowest for IGV1 (41%).
  • Rebleeding rates were significantly higher for IGV1 (53%) compared to GOV1 (5.5%) and GOV2 (19%).

Conclusions:

  • Gastric variceal sclerotherapy is effective for arresting acute bleeding and achieving obliteration.
  • Treatment success is significantly higher for gastroesophageal varices (GOV1 and GOV2) than isolated gastric varices (IGV1).
  • Alternative therapies should be explored for patients with IGV1 due to poor sclerotherapy outcomes and high rebleeding risk.
Abstract

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...